Loading company details...
Beta
Latest Form 4 (Feb 27, 2026): Pierre Jacquet (Director): Grant/Award of 66,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 27, 2026 | Pierre Jacquet | Grant/Award | 66,000 | n/a |
| Feb 27, 2026 | Marc J. Yoskowitz | Grant/Award | 66,000 | n/a |
| Feb 27, 2026 | Daniel Shames | Grant/Award | 66,000 | n/a |
| Feb 27, 2026 | Anders Ekblom | Grant/Award | 66,000 | n/a |
| Feb 27, 2026 | Jeremy Bender | Grant/Award | 66,000 | n/a |
| Feb 27, 2026 | Deepika Pakianathan | Grant/Award | 66,000 | n/a |
| Feb 27, 2026 | Annalisa Jenkins | Grant/Award | 66,000 | n/a |
| Feb 27, 2026 | Michael S. Wyzga | Grant/Award | 66,000 | n/a |
| Feb 2, 2026 | John A. Lewicki, Chief Scientific Officer | Grant/Award | 139,913 | n/a |
| Feb 2, 2026 | Alexandra Hughes-Wilson, Chief Patient Access and Commercial Planning | Grant/Award | 183,750 | n/a |